BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2409562)

  • 1. Clonidine reverses methylxanthine-induced potentiation of baclofen antinociception.
    Steardo L; Sawynok J
    Pharmacol Biochem Behav; 1985 May; 22(5):905-7. PubMed ID: 2409562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine.
    Sawynok J; Reid A
    Brain Res; 1986 Oct; 386(1-2):341-50. PubMed ID: 3096496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylxanthine activation of noradrenergic unit activity and reversal by clonidine.
    Grant SJ; Redmond DE
    Eur J Pharmacol; 1982 Nov; 85(1):105-9. PubMed ID: 6185350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.
    Sawynok J; Reid A
    Neurochem Res; 1986 May; 11(5):723-31. PubMed ID: 2873522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline-induced potentiation of the antinociceptive action of baclofen.
    Sawynok J
    Br J Pharmacol; 1983 Feb; 78(2):353-7. PubMed ID: 6831116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of descending noradrenergic pathways in the antinociceptive effect of baclofen.
    Sawynok J; Dickson C
    Brain Res; 1985 May; 335(1):89-97. PubMed ID: 3924340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain.
    Galloway MP; Roth RH
    J Neurochem; 1983 Jan; 40(1):246-51. PubMed ID: 6184449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of drugs which influence noradrenergic activity on metenkephalin levels in specific brain areas.
    Morris B; Livingston A
    Neuropeptides; 1986 Jan; 7(1):27-30. PubMed ID: 2419782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
    Kleven MS; Sparber SB
    Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of antinociceptive action of flupirtine in the rat.
    Szelenyi I; Nickel B; Borbe HO; Brune K
    Br J Pharmacol; 1989 Jul; 97(3):835-42. PubMed ID: 2569346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of 3-isobutylmethylxanthine: effects on central noradrenergic systems in vivo.
    Galloway MP; Roth RH
    J Pharmacol Exp Ther; 1983 Oct; 227(1):1-8. PubMed ID: 6194283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome.
    Grant SJ; Redmond DE
    Pharmacol Biochem Behav; 1982 Oct; 17(4):655-8. PubMed ID: 6184732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamines as mediators of the antinociceptive effect of baclofen.
    Sawynok J
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(1):54-7. PubMed ID: 6877393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M; Baeyens JM
    Br J Pharmacol; 1993 Nov; 110(3):1049-54. PubMed ID: 7905339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
    Reinhard JF; Galloway MP; Roth RH
    J Pharmacol Exp Ther; 1983 Sep; 226(3):764-9. PubMed ID: 6193267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ascending and descending serotonergic pathways in the antinociceptive effect of baclofen.
    Sawynok J; Reid A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):359-65. PubMed ID: 3405312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
    Andurkar SV; Gendler L; Gulati A
    Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine mediates calcium-induced antinociception and potentiation of noradrenergic antinociception in the spinal cord.
    Sawynok J; Reid A; Isbrucker R
    Brain Res; 1990 Aug; 524(2):187-95. PubMed ID: 2127235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord.
    Sawynok J; Dickson C
    Pharmacology; 1985; 31(5):248-59. PubMed ID: 2999839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic agonist administration into the central nucleus of the amygdala increases the tail-flick latency in lightly anesthetized rats.
    Ortiz JP; Heinricher MM; Selden NR
    Neuroscience; 2007 Sep; 148(3):737-43. PubMed ID: 17706366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.